Pakistan to start manufacturing COVID-19 treatment drug soon: Dr. Zafar

Pakistan to start manufacturing COVID-19 treatment drug soon: Dr. Zafar

ISLAMABAD, Pakistan: The Prime Minister’s Special Assistant on National Health Services Dr. Zafar Mirza has said that Pakistan will soon start manufacturing breakthrough COVID-19 treatment drug Remdesivir under a license from the US Pharmaceutical Company Gilead.

While addressing a news conference in Islamabad on Friday, he said that a Pakistani Pharmaceutical Company has concluded its voluntary licensing agreement with the US Pharmaceutical Company Gilead for the manufacturing and sale of Remdesivir.

   

The Special Assistant said that Pakistan is among the five Countries with which the US Company has signed a licensing agreement for manufacturing the drug.COVID-19 treatment drug - The Prime Minister’s Special Assistant on National Health Services Dr. Zafar Mirza has said that Pakistan will soon start manufacturing breakthrough COVID-19 treatment drug Remdesivir under a license from the US Pharmaceutical Company Gilead. While addressing a news conference in Islamabad on Friday, he said that a Pakistani Pharmaceutical Company has concluded its voluntary licensing agreement with the US Pharmaceutical Company Gilead for the manufacturing and sale of Remdesivir. The Special Assistant said that Pakistan is among the five Countries with which the US Company has signed licensing agreement for manufacturing the drug. Dr. Zafar Mirza said that the production of the medicine can commence as early as eight weeks after the necessary regulatory approvals are obtained. Furthermore, he said that the development represents an important step forward for Pakistan on the health, economic and diplomacy fronts. The Special Assistant said that it helps provide our citizens and frontline healthcare workers access to the latest treatment for the pandemic in a fast-track manner. Dr. Zafar Mirza said that Pakistan will also be able to export the medicine to 127 Countries facing Coronavirus pandemic.

Dr. Zafar Mirza said that the production of the medicine can commence as early as eight weeks after the necessary regulatory approvals are obtained.

Furthermore, he said that the development represents an important step forward for Pakistan on the health, economic and diplomacy fronts.

The Special Assistant said that it helps provide our citizens and frontline healthcare workers access to the latest treatment for the pandemic in a fast-track manner.

Dr. Zafar Mirza said that Pakistan will also be able to export the medicine to 127 Countries facing Coronavirus pandemic.

Mati
Mati
Mati-Ullah is the Online Editor For DND. He is the real man to handle the team around the Country and get news from them and provide to you instantly.

Must read

Recent News

Culprits of Shangla attack will be brought to justice, Mohsin Naqvi assures Chinese

0
ISLAMABAD, Pakistan: The Interior Minister Mohsin Naqvi on Friday visited the Chinese Embassy in Islamabad and met the Special Investigation Team that had arrived...

Pakistan’s foreign reserves reach $13.43 billion

0
Total reserves: $13.4 billion, up by $36.9 million SBP reserves: $8.0 billion, up $4 million Commercial Banks reserves: $5.4 billion, up by $32.9...

AUD to INR: Australian Dollar to Indian Rupee Today – 29 March 2024

0
The Australian Dollar (AUD) was trading at 54.28 as per the Indian Rupee (INR) on Friday.Currently, Indians are now the second-largest migrant group in...

USD to PKR: USD Dollar Rate in Pakistan Today – 29 March 2024

0
The US Dollar (USD) was being bought and sold at Rs 278.2 and Rs 280.9 in the Open Market against the Pakistani Rupee (PKR)...

Gold Price in Pakistan Today – 29 March 2024

0
On Friday (March 29, 2024), the gold rate for one tola of 24-karat in Karachi, Pakistan, is Rs 229,900.000.It's important to note that gold...
Advertisement